Prodigiosin purification from Serratia marcescens M10 and its antitumor activities

Vu Trong Luong; Nguyen Sy Le Thanh; Do Thi Tuyen; Do Thi Cuc; Do Thi Thao

doi:10.15625/1811-4989/15722

Author affiliations

Authors

Vu Trong Luong
Nguyen Sy Le Thanh
Do Thi Tuyen
Do Thi Cuc
Do Thi Thao https://orcid.org/0000-0002-8760-264X

DOI:

https://doi.org/10.15625/1811-4989/15722

Keywords:

BALB/c mice, Lewis lung carcinoma, Prodigiosin, Serratia marcescens, tumor

Abstract

Prodigiosin (Pg) is a bright red pigment, which is produced by gram negative and gram positive bacteria including Serratia marcescens, Hahella chejuensis, Vibrio psychroerythrus, Streptomyces coelicolor and many other marine bacteria such as Pseudomonas sp., Vibrio sp. Pg induces apoptosis in different kinds of cancer cells with low toxicity on normal cells. In this study, we purified Pg from solid fermentation of S. marcescens M10 strain and assessed its anticancer activity in tumorized mice. The results showed that Pg was purified by running through a silicagel 60 column with a suitable solvent system of n-hexane:toluene at the rate of 1:1 (v/v) combined with toluene:ethyl acetate at the rate of 9:1 (v/v). TLC plate was used to test the presence of active substances with separation solvent n-hexane:ethyl acetate ratio of 1:1 (v/v). The purity of fractions tested by high performance liquid chromatography method showed as 98%. Purified fractions also showed promising anti-tumor activity in Lewis lung carcinoma induced tumors in BALB/c mice. The tumor volumes in Pg treated groups decreased by 34.18% after 28 days of administration.

Downloads

Download data is not yet available.

References

Dan Li, Jun Liu, Xin Wang, Di Kong, Wei Du, Hongbo Li, Chung-Yun Hse, Todd Shupe, Dongpo Zhou, and Kai Zhao (2018), Biological Potential and Mechanism of Prodigiosin from Serratia marcescens Subsp. lawsoniana in Human Choriocarcinoma and Prostate Cancer Cell Lines, Int J Mol Sci. Nov; 19(11): 3465

Do, T. T., Do, T. P., Nguyen, T. N., Nguyen, T. C., Vu, T. T. P., & Nguyen, T. G. A. (2019). Nanoliposomal L-Asparaginase and Its Antitumor Activities in Lewis Lung Carcinoma Tumor-Induced BALB/c Mice. Adv Mater Sci Eng, 2019, 1–8.

Đỗ Thị Thảo, Nguyễn Thị Nga, Nguyễn Thị Trang, Nguyễn Thị Cúc, Đỗ Thị Phương (2008). Gây u thực nghiệm trên chuột bằng dòng tế bào ung thư Lewis Lung Carcinoma. Tạp chí Công nghệ Sinh học, 6(4A): 619-624.

Eun-Ok Lee, Hyo-Jung Lee, Hwa-Soo Hwang, Kyoo-Seok Ahn, Chanhee Chae, Kyung-Sun Kang, Junxuan Lu and Sung-Hoon Kim (2006). Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities. Carcinogenesis, 27(10): 2059-2069.

Harned R. L., (1954). The production of prodigiosin by submerged growth of Serratia marcescens. Appl Microbiol, 2(6): 365-368.

Hyo Jeong Lee, Hyo Jung Lee, Eun Ok Lee, Jae Ho Lee, Kuen Sung Lee, Kwan Hyun Kim, Sung-Hoon Kim and Junxuan Lü (2009). In vivo Anti-Cancer Activity of Korean Angelica Gigas and its Major Pyranocoumarin Decursin. The American Journal of Chinese Medicine, 37(1): 127-142.

Iigo M, Hoshi A, Kadosawa H, Fujigaki M (1991). Antitumor Activity and Metabolism of a New Anthracycline-containing Fluorine (ME2303) in Lewis Lung Carcinoma-bearing Mice. J Cancer Res, 82: 1317-1321

Kavitha R, Aiswariya S, Chandana MG Ratnavali (2010). Anticancer activity of red pigment from Serratia marcescensin human cervix carcinoma, Int J Pharm Tech Res, 2(1): 784-787.

Maheswarappa, G, Kavitha, D, Vijayarani, K and Kumanan (2013). Prodigiosin as anticencer drug Production from bacteria of termite gut. Indian Journal of Basic and Applied Medical Research, 3, 257-266.

Kimura Y, Taniguchi M, Baba K (2004). Antitumor and Antimetastatic Activities of 4-Hydroxyderricin Isolated fromAngelica keiskeiRoots. Planta Medica, 70(3), 211–219.

Montaner B and Pérez-Tomás R (2003). The prodigiosins: A new family of anticancer drugs. Curr Cancer Drug Tar, 3: 57-65.

Pérez-Tomás R, Montaner B, Llagostera E, Soto-Cerrato V (2003), The prodigiosins, proapoptotic drugs with anticancer properties, Biochem Pharmacol, 66(8): 1447-1452.

Priya, K A, Satheesh, S, Ashokkumar, B, Varalakshmi, P, Selvakumar, G and Sivakumar, N. (2013). Antifouling Activily of Prodigiosin from Estuarine Isolate of Serratia marcescens CMST 07. Microbiogical Research In Agroecosystem Management. Google Patents

Ramina, Samira, M. and Yousif, M. (2009). The role of red pigment produced by Serratia marcescens as antibacterial and plasmid curing agent. J. duhk univ, 12, 268-274.

Song Y, Liu G, Li J, Huang H, Zhang X, Zhang H, Ju J (2015). Cytotoxic and antibacterial angucycline- and prodigiosin-analogues from the deep-sea derived Streptomyces sp. SCSIO 11594. Mar Drugs, 13(3):1304-16.

Song MJ et al. (2006) Purification and characterization of prodigiosin produced by integrated bioreactor from Serratia sp. KH-95. J. Biosci. Bioeng. 101:157-161

Thuy TT, Thien DD, Hung TQ, Tam NT, Anh NTH, Trang NT, Nga NT, Sung TV, Delfino DV, Thao DT. In vivo anticancer activity of maesopsin 4-O-β-glucoside isolated from leaves of Artocarpus tonkinensis A. Chev. Ex Gagnep. Asian Pac J Trop Med. 2016; 9(4): 351-356